Literature DB >> 17039231

Molecular pathways in follicular lymphoma.

R J Bende1, L A Smit, C J M van Noesel.   

Abstract

Follicular lymphoma (FL) is one of the most common B-cell non-Hodgkin's lymphomas. The initiating genetic event found in approximately 90% of FL is the t(14;18), causing constitutive expression of the antiapoptotic BCL-2 protein. The exact secondary alterations leading to full FL development are still poorly defined. In this review, we address (i) the genetic pathways associated with tumorigenesis and progression of FL, (ii) the role of micro-environmental factors with emphasis on B-cell receptor ligands and (iii) lymphoma models in mice and what they teach us about lymphomagenesis in man.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17039231     DOI: 10.1038/sj.leu.2404426

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  50 in total

1.  Origin and migration of follicular lymphoma cells.

Authors:  Philip M Kluin
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

2.  Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma.

Authors:  Milena Krajnović; Milica Radojković; Radoslav Davidović; Bogomir Dimitrijević; Koviljka Krtolica
Journal:  Med Oncol       Date:  2012-12-30       Impact factor: 3.064

3.  Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse.

Authors:  Martin Wartenberg; Peter Vasil; Christian Meyer zum Bueschenfelde; German Ott; Andreas Rosenwald; Falko Fend; Marcus Kremer
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

4.  Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma.

Authors:  Lu He; Jin-Hua Liang; Jia-Zhu Wu; Yue Li; Shu-Chao Qin; Yi Miao; Yu-Jie Wu; Yan Wang; Li Wang; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Tumour Biol       Date:  2016-07-07

5.  Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Authors:  Hongxiu Li; Mark S Kaminski; Yifeng Li; Mehmet Yildiz; Peter Ouillette; Siân Jones; Heather Fox; Kathryn Jacobi; Kamlai Saiya-Cork; Dale Bixby; Daniel Lebovic; Diane Roulston; Kerby Shedden; Michael Sabel; Lawrence Marentette; Vincent Cimmino; Alfred E Chang; Sami N Malek
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

6.  Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.

Authors:  Soung-Chul Cha; Hong Qin; Shibichakravarthy Kannan; Seema Rawal; Leticia S Watkins; Flavio E Baio; Weiguo Wu; Juliana Ong; Jinsong Wei; Benjamin Kwak; Sang Kim; Michael S Popescu; Daniel S Paick; Kunhwa Kim; Amber Luong; Richard E Davis; Harry W Schroeder; Larry W Kwak; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

7.  A Systematic Review of Carcinogenic Outcomes and Potential Mechanisms from Exposure to 2,4-D and MCPA in the Environment.

Authors:  Katherine von Stackelberg
Journal:  J Toxicol       Date:  2013-02-26

8.  Circulating t(14;18)-positive cells in healthy individuals: association with age and sex but not with smoking.

Authors:  Carsten Hirt; Kerstin Weitmann; Frank Schüler; Thomas Kiefer; Charles S Rabkin; Wolfgang Hoffmann; Gottfried Dölken
Journal:  Leuk Lymphoma       Date:  2013-05-07

Review 9.  Economic burden of follicular non-Hodgkin's lymphoma.

Authors:  Talia Foster; Jeffrey D Miller; Mark E Boye; Mason W Russell
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  A molecular analysis of biclonal follicular lymphoma: further evidence for bone marrow origin and clonal selection.

Authors:  Yuichi Nakamura; Yasutaka Sato; Katsuhiko Yoshida; Emi Kakegawa; Yoshihiro Ito; Atsushi Seyama; Hidekazu Kayano; Masami Bessho
Journal:  Eur J Haematol       Date:  2009-02-05       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.